Literature DB >> 430176

Reversible functional asplenia in chronic aggressive hepatitis.

V M Dhawan, R P Spencer, J J Sziklas.   

Abstract

A 61-year-old man presented with aggressive hepatitis. Howell-Jolly bodies were present in circulating erythrocytes and the spleen failed to accumulate intravenously administered Tc-99 m sulfur colloid. The patient thus demonstrated functional asplenia. He was treated with high doses of steroids. Four years later, Howell-Jolly bodies were no longer present in circulating erythrocytes. In addition, the spleen had regained the ability to accumulate intravenously injected radiocolloid. Hence, the patient had reversed his functional asplenia. The reported cases of this disorder (reversible functional asplenia) were reviewed and a preliminary classification was proposed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 430176

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  5 in total

1.  Autosplenectomy: rare syndrome in autoimmunopathy.

Authors:  J Leipe; A J Hueber; S Kallert; J Rech; H Schulze-Koops
Journal:  Ann Rheum Dis       Date:  2007-04       Impact factor: 19.103

2.  Total non-visualization of the spleen on 99mTc-sulfur colloid and 113mIn-chloride blood pool images.

Authors:  W J Shih; B J Sauerbrunn; H R Bates
Journal:  Eur J Nucl Med       Date:  1982

3.  Functional hyposplenism in alcoholic liver disease: a toxic effect of alcohol?

Authors:  A F Muller; P J Toghill
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

Review 4.  Hyposplenism--a review.

Authors:  P N Foster; M S Losowsky
Journal:  J R Coll Physicians Lond       Date:  1987-07

5.  Howell-Jolly bodies and liver-spleen scanning for assessment of splenic filtrative function yields discordant results in renal transplant recipients.

Authors:  Nordeval Cavalcante Araújo; Margarida Maria Camões Orlando; Moises Bonifácio Neves; Suzimar Silveira Rioja; Stella Beatriz Gonçalves de Lucena; Carlos Alberto Mandarim-de-Lacerda
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.